Mathematical method developed to predict cancer and drug-specific immunotherapy efficacy

HOUSTON-(Feb. 1, 2021) – Houston Methodist researchers have developed a mathematical model to predict how specific cancers will respond to immunotherapy treatments, thus enhancing chances for successful treatments from a wide variety of cancer-immunotherapy drug combinations. The results were published last month in Nature Biomedical Engineering in collaboration with researchers at MD Anderson Cancer Center.…

Details

NYU Dentistry awarded $1.9M NIH grant to study mitochondrial changes behind stroke, heart attack

The National Institute of General Medical Sciences, part of the National Institutes of Health (NIH), has awarded NYU College of Dentistry’s Evgeny Pavlov a grant to study a phenomenon called mitochondrial permeability transition, one of the central causes of tissue damage during stroke and heart attack. The five-year, $1.9 million grant (R35GM139615) begins February 1.…

Details

Nutrition, companionship reduce pain in mice with sickle cell disease, UCI-led study finds

Irvine, Calif. — Researchers from the University of California, Irvine and the University of Minnesota have found that an enriched diet and companionship can reduce pain in mice with sickle cell disease by increasing serotonin. They also discovered that duloxetine, an antidepressant that boosts serotonin levels, could be an alternative to opioids in treating chronic…

Details

Mayo Clinic research yields breakthrough in mobile determination of QT prolongation

ROCHESTER, Minn. — Researchers from Mayo Clinic and AliveCor Inc. have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. This research has yielded a breakthrough in determining the health of the electrical recharging system in a patient’s heart. The researchers determined that…

Details